• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤干细胞及其血管生态位:它们是否相互受益?

Cancer stem cells and their vascular niche: Do they benefit from each other?

机构信息

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China; Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China.

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China; Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038, China.

出版信息

Cancer Lett. 2016 Oct 1;380(2):561-567. doi: 10.1016/j.canlet.2015.05.010. Epub 2015 May 12.

DOI:10.1016/j.canlet.2015.05.010
PMID:25979233
Abstract

Cancer stem cells (CSCs) locate in and interact with particular vascular niches to maintain their stemness. CSCs induce, remodel and participate in the formation of microenvironmental niches to facilitate survival, stemness and escape from radio-/chemo-/bio-therapies. Neovasculature in tumor is often basement membrane-deficient and enriched with CSC-derived endothelial cells (ECs) and other mural cells, which may promote tumor invasion and metastasis. The aim of this review is to summarize recent findings about the crosstalk between CSCs and their vascular niches and discuss the potential therapeutic significance.

摘要

癌症干细胞(CSCs)位于特定的血管龛位并与之相互作用,以维持其干细胞特性。CSCs 诱导、重塑并参与微环境龛位的形成,以促进其存活、干细胞特性和逃避放化疗/生物治疗。肿瘤中的新生血管通常缺乏基底膜,并富含 CSC 衍生的内皮细胞(EC)和其他壁细胞,这可能促进肿瘤的侵袭和转移。本综述的目的是总结 CSCs 与其血管龛位之间相互作用的最新发现,并讨论其潜在的治疗意义。

相似文献

1
Cancer stem cells and their vascular niche: Do they benefit from each other?肿瘤干细胞及其血管生态位:它们是否相互受益?
Cancer Lett. 2016 Oct 1;380(2):561-567. doi: 10.1016/j.canlet.2015.05.010. Epub 2015 May 12.
2
Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma.肝细胞癌中癌症干细胞与血管生成之间的正反馈回路。
Cancer Lett. 2016 Sep 1;379(2):213-9. doi: 10.1016/j.canlet.2016.03.014. Epub 2016 Apr 20.
3
Cancer stem cells switch on tumor neovascularization.肿瘤干细胞启动肿瘤血管生成。
Curr Mol Med. 2011 Feb;11(1):69-75. doi: 10.2174/156652411794474383.
4
Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.作为肿瘤微环境中抗血管生成治疗靶点的经典和非经典促血管生成因子
Cancer Lett. 2016 Sep 28;380(1):216-26. doi: 10.1016/j.canlet.2015.07.028. Epub 2015 Jul 31.
5
Resistance to metronomic chemotherapy and ways to overcome it.对节拍化疗的耐药性及其克服方法。
Cancer Lett. 2017 Aug 1;400:311-318. doi: 10.1016/j.canlet.2017.02.027. Epub 2017 Mar 1.
6
Current insights into the association of Nestin with tumor angiogenesis.巢蛋白与肿瘤血管生成关联的当前见解。
J BUON. 2015 May-Jun;20(3):699-706.
7
Consice review: Contribution of cancer stem cells to neovascularization.简明综述:癌症干细胞对血管生成的贡献。
Stem Cells. 2011 Jun;29(6):888-94. doi: 10.1002/stem.650.
8
Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?癌症干细胞休眠的血管决定因素——年龄和凝血系统起作用吗?
APMIS. 2008 Jul-Aug;116(7-8):660-76. doi: 10.1111/j.1600-0463.2008.01058.x.
9
Tumor vasculature and glioma stem cells: Contributions to glioma progression.肿瘤血管和神经胶质瘤干细胞:对神经胶质瘤进展的贡献。
Cancer Lett. 2016 Oct 1;380(2):545-551. doi: 10.1016/j.canlet.2014.12.028. Epub 2014 Dec 16.
10
Tumor microenvironment for cancer stem cells.肿瘤微环境与癌症干细胞
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):197-205. doi: 10.1016/j.addr.2015.08.005. Epub 2015 Sep 8.

引用本文的文献

1
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.肿瘤微环境:癌症干细胞免疫治疗的龛位。
Stem Cell Rev Rep. 2024 Jan;20(1):3-24. doi: 10.1007/s12015-023-10639-6. Epub 2023 Oct 20.
2
Cancer cell plasticity during tumor progression, metastasis and response to therapy.肿瘤进展、转移及对治疗的反应过程中的癌细胞可塑性。
Nat Cancer. 2023 Aug;4(8):1063-1082. doi: 10.1038/s43018-023-00595-y. Epub 2023 Aug 3.
3
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance.
干性标志物醛脱氢酶1家族成员A1(ALDH1A1)如何与肿瘤血管生成、进展及耐药性相关联。
Cancer Drug Resist. 2020 Mar 19;3(1):26-37. doi: 10.20517/cdr.2019.70. eCollection 2020.
4
Emerging Role of E2F Family in Cancer Stem Cells.E2F家族在癌症干细胞中的新兴作用。
Front Oncol. 2021 Aug 12;11:723137. doi: 10.3389/fonc.2021.723137. eCollection 2021.
5
Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL.癌症干细胞对TRAIL的适应性和抗性机制背后
Pharmaceutics. 2021 Jul 10;13(7):1062. doi: 10.3390/pharmaceutics13071062.
6
Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.蛋白酶调节癌症干细胞特性并重塑其微环境。
J Histochem Cytochem. 2021 Dec;69(12):775-794. doi: 10.1369/00221554211035192. Epub 2021 Jul 26.
7
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling.周细胞通过 CCL5-CCR5 旁分泌信号增强胶质母细胞瘤细胞对替莫唑胺的耐药性。
Cell Res. 2021 Oct;31(10):1072-1087. doi: 10.1038/s41422-021-00528-3. Epub 2021 Jul 8.
8
Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective.血管内皮细胞中的Notch信号通路、血管生成与肿瘤进展:最新进展与展望
Front Cell Dev Biol. 2021 Feb 16;9:642352. doi: 10.3389/fcell.2021.642352. eCollection 2021.
9
The CXCL12 Crossroads in Cancer Stem Cells and Their Niche.癌症干细胞及其微环境中的CXCL12交叉点
Cancers (Basel). 2021 Jan 26;13(3):469. doi: 10.3390/cancers13030469.
10
Cancer stem cells and strategies for targeted drug delivery.肿瘤干细胞与靶向药物递送策略。
Drug Deliv Transl Res. 2021 Oct;11(5):1779-1805. doi: 10.1007/s13346-020-00863-9. Epub 2020 Oct 23.